Shari B Brosnahan
Overview
    Explore the profile of Shari B Brosnahan including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              33
            
            
              Citations
              262
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Shah D, Thaweethai T, Karlson E, Bonilla H, Horne B, Mullington J, et al.
  
  
    JAMA Netw Open
    . 2025 Jan;
          8(1):e2455430.
    
    PMID: 39841477
  
  
          Importance: A substantial number of individuals worldwide experience long COVID, or post-COVID condition. Other postviral and autoimmune conditions have a female predominance, but whether the same is true for long...
      
2.
        
    
    Geng L, Erlandson K, Hornig M, Letts R, Selvaggi C, Ashktorab H, et al.
  
  
    JAMA
    . 2024 Dec;
          333(8):694-700.
    
    PMID: 39693079
  
  
          Importance: Classification of persons with long COVID (LC) or post-COVID-19 condition must encompass the complexity and heterogeneity of the condition. Iterative refinement of the classification index for research is needed...
      
3.
        
    
    Nelson N, Wong K, Mahoney I, Malik T, Rudym D, Lesko M, et al.
  
  
    J Heart Lung Transplant
    . 2024 Nov;
          44(3):422-434.
    
    PMID: 39561864
  
  
          Background: Lower airway enrichment with oral commensals has been previously associated with severe primary graft dysfunction (PGD) after lung transplantation (LT). We aimed to determine whether this dysbiotic signature is...
      
4.
        
    
    Johnson S, Abedian S, Sturmer T, Huling J, Lewis V C, Buse J, et al.
  
  
    Diabetes Care
    . 2024 Sep;
          47(11):1930-1940.
    
    PMID: 39287394
  
  
          Objective: Studies show metformin use before and during SARS-CoV-2 infection reduces severe COVID-19 and postacute sequelae of SARS-CoV-2 (PASC) in adults. Our objective was to describe the incidence of PASC...
      
5.
        
    
    Barnett C, Krolikowski K, Postelnicu R, Mukherjee V, Sulaiman I, Chung M, et al.
  
  
    ERJ Open Res
    . 2024 Jul;
          10(4).
    
    PMID: 38978558
  
  
          Introduction: Mounting evidence indicates that an individual's humoral adaptive immune response plays a critical role in the setting of SARS-CoV-2 infection, and that the efficiency of the response correlates with...
      
6.
        
    
    Natalini J, Wong K, Nelson N, Wu B, Rudym D, Lesko M, et al.
  
  
    Am J Respir Crit Care Med
    . 2024 Feb;
          209(12):1463-1476.
    
    PMID: 38358857
  
  
          Acute cellular rejection (ACR) after lung transplant is a leading risk factor for chronic lung allograft dysfunction. Prior studies have demonstrated dynamic microbial changes occurring within the allograft and gut...
      
7.
        
    
    Horwitz L, Thaweethai T, Brosnahan S, Cicek M, Fitzgerald M, Goldman J, et al.
  
  
    PLoS One
    . 2023 Jun;
          18(6):e0286297.
    
    PMID: 37352211
  
  
          Importance: SARS-CoV-2 infection can result in ongoing, relapsing, or new symptoms or other health effects after the acute phase of infection; termed post-acute sequelae of SARS-CoV-2 infection (PASC), or long...
      
8.
        
    
    Bonfim L, S Guerini I, G Zambon M, Pires G, Silva A, Gobatto A, et al.
  
  
    J Crit Care
    . 2023 May;
          77:154344.
    
    PMID: 37244209
  
  
          Purpose: The optimal amount of anticoagulation for critically ill COVID-19 patients is controversial. Therefore, we aimed to evaluate the efficacy and safety of escalated doses of anticoagulation in critically ill...
      
9.
        
    
    Mandel H, Colleen G, Abedian S, Ammar N, Bailey L, Bennett T, et al.
  
  
    Sleep
    . 2023 May;
          46(9).
    
    PMID: 37166330
  
  
          Study Objectives: Obstructive sleep apnea (OSA) has been associated with more severe acute coronavirus disease-2019 (COVID-19) outcomes. We assessed OSA as a potential risk factor for Post-Acute Sequelae of SARS-CoV-2...
      
10.
        
    
    Chung J, Brosnahan S, Islam S, Altshuler D, Spiegler P, Li W, et al.
  
  
    J Crit Care
    . 2023 Apr;
          76:154291.
    
    PMID: 37043893
  
  
          Purpose: Tocilizumab has been shown to decrease mortality when used concomitantly with steroids in COVID-19 with 8 mg/kg (max 800 mg) being the standard dose. Our study sought to assess...